vs
Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and FGI Industries Ltd. (FGI). Click either name above to swap in a different company.
FGI Industries Ltd. is the larger business by last-quarter revenue ($30.5M vs $20.0M, roughly 1.5× AGIOS PHARMACEUTICALS, INC.). FGI Industries Ltd. runs the higher net margin — -8.6% vs -541.1%, a 532.5% gap on every dollar of revenue. On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs -14.4%). FGI Industries Ltd. produced more free cash flow last quarter ($2.3M vs $-97.3M). Over the past eight quarters, AGIOS PHARMACEUTICALS, INC.'s revenue compounded faster (56.1% CAGR vs -0.5%).
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
FGI Industries Ltd is a global designer, manufacturer and distributor of kitchen and bath products, home organization solutions, and home improvement goods. It serves major retail chains, home specialty stores and e-commerce platforms across North America, Europe and the Asia-Pacific region.
AGIO vs FGI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.0M | $30.5M |
| Net Profit | $-108.0M | $-2.6M |
| Gross Margin | 90.6% | 26.7% |
| Operating Margin | -608.9% | -2.2% |
| Net Margin | -541.1% | -8.6% |
| Revenue YoY | 86.1% | -14.4% |
| Net Profit YoY | -11.9% | -553.1% |
| EPS (diluted) | $-1.86 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.0M | $30.5M | ||
| Q3 25 | $12.9M | $35.8M | ||
| Q2 25 | $12.5M | $31.0M | ||
| Q1 25 | $8.7M | $33.2M | ||
| Q4 24 | $10.7M | $35.6M | ||
| Q3 24 | $9.0M | $36.1M | ||
| Q2 24 | $8.6M | $29.4M | ||
| Q1 24 | $8.2M | $30.8M |
| Q4 25 | $-108.0M | $-2.6M | ||
| Q3 25 | $-103.4M | $-1.7M | ||
| Q2 25 | $-112.0M | $-1.2M | ||
| Q1 25 | $-89.3M | $-629.1K | ||
| Q4 24 | $-96.5M | $-402.3K | ||
| Q3 24 | $947.9M | $-550.1K | ||
| Q2 24 | $-96.1M | $163.6K | ||
| Q1 24 | $-81.5M | $-412.2K |
| Q4 25 | 90.6% | 26.7% | ||
| Q3 25 | 87.0% | 26.5% | ||
| Q2 25 | 86.3% | 28.1% | ||
| Q1 25 | 87.6% | 26.8% | ||
| Q4 24 | 88.3% | 24.6% | ||
| Q3 24 | 91.3% | 25.8% | ||
| Q2 24 | 82.6% | 30.5% | ||
| Q1 24 | 92.3% | 27.4% |
| Q4 25 | -608.9% | -2.2% | ||
| Q3 25 | -907.4% | 1.0% | ||
| Q2 25 | -1020.1% | -2.7% | ||
| Q1 25 | -1222.0% | -3.9% | ||
| Q4 24 | -1165.3% | -3.5% | ||
| Q3 24 | -1146.9% | -0.2% | ||
| Q2 24 | -1228.3% | -1.5% | ||
| Q1 24 | -1124.3% | -1.0% |
| Q4 25 | -541.1% | -8.6% | ||
| Q3 25 | -803.1% | -4.6% | ||
| Q2 25 | -899.4% | -4.0% | ||
| Q1 25 | -1023.3% | -1.9% | ||
| Q4 24 | -899.6% | -1.1% | ||
| Q3 24 | 10574.7% | -1.5% | ||
| Q2 24 | -1115.7% | 0.6% | ||
| Q1 24 | -995.8% | -1.3% |
| Q4 25 | $-1.86 | $-1.63 | ||
| Q3 25 | $-1.78 | $-0.86 | ||
| Q2 25 | $-1.93 | $-0.64 | ||
| Q1 25 | $-1.55 | $-0.07 | ||
| Q4 24 | $-1.44 | $-0.38 | ||
| Q3 24 | $16.22 | $-0.29 | ||
| Q2 24 | $-1.69 | $0.08 | ||
| Q1 24 | $-1.45 | $-0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.1M | $1.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $17.3M |
| Total Assets | $1.3B | $69.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.1M | $1.9M | ||
| Q3 25 | $92.7M | $1.9M | ||
| Q2 25 | $80.9M | $2.5M | ||
| Q1 25 | $79.0M | $1.2M | ||
| Q4 24 | $76.2M | $4.6M | ||
| Q3 24 | $253.7M | $3.0M | ||
| Q2 24 | $84.5M | $1.3M | ||
| Q1 24 | $118.8M | $3.3M |
| Q4 25 | $1.2B | $17.3M | ||
| Q3 25 | $1.3B | $19.7M | ||
| Q2 25 | $1.4B | $21.3M | ||
| Q1 25 | $1.5B | $21.8M | ||
| Q4 24 | $1.5B | $22.3M | ||
| Q3 24 | $1.6B | $23.5M | ||
| Q2 24 | $660.5M | $23.8M | ||
| Q1 24 | $743.9M | $23.9M |
| Q4 25 | $1.3B | $69.5M | ||
| Q3 25 | $1.4B | $73.0M | ||
| Q2 25 | $1.5B | $71.7M | ||
| Q1 25 | $1.6B | $68.5M | ||
| Q4 24 | $1.7B | $75.5M | ||
| Q3 24 | $1.8B | $74.7M | ||
| Q2 24 | $773.1M | $69.9M | ||
| Q1 24 | $849.7M | $68.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.2M | $2.3M |
| Free Cash FlowOCF − Capex | $-97.3M | $2.3M |
| FCF MarginFCF / Revenue | -487.5% | 7.5% |
| Capex IntensityCapex / Revenue | 5.6% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-377.3M | $-212.5K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-96.2M | $2.3M | ||
| Q3 25 | $-88.2M | $-1.9M | ||
| Q2 25 | $-77.1M | $7.6M | ||
| Q1 25 | $-111.5M | $-7.4M | ||
| Q4 24 | $-133.2M | $617.4K | ||
| Q3 24 | $-84.2M | $-915.0K | ||
| Q2 24 | $-72.6M | $862.1K | ||
| Q1 24 | $-99.9M | $-8.0M |
| Q4 25 | $-97.3M | $2.3M | ||
| Q3 25 | $-89.7M | $-2.1M | ||
| Q2 25 | $-78.0M | $7.4M | ||
| Q1 25 | $-112.3M | $-7.7M | ||
| Q4 24 | $-134.1M | $-214.1K | ||
| Q3 24 | $-84.6M | $-1.1M | ||
| Q2 24 | $-72.7M | $281.5K | ||
| Q1 24 | $-100.0M | $-8.6M |
| Q4 25 | -487.5% | 7.5% | ||
| Q3 25 | -696.5% | -5.9% | ||
| Q2 25 | -626.2% | 23.8% | ||
| Q1 25 | -1286.4% | -23.3% | ||
| Q4 24 | -1250.1% | -0.6% | ||
| Q3 24 | -944.2% | -3.0% | ||
| Q2 24 | -844.4% | 1.0% | ||
| Q1 24 | -1221.2% | -28.0% |
| Q4 25 | 5.6% | 0.2% | ||
| Q3 25 | 12.1% | 0.7% | ||
| Q2 25 | 7.0% | 0.7% | ||
| Q1 25 | 8.8% | 1.1% | ||
| Q4 24 | 9.0% | 2.3% | ||
| Q3 24 | 4.7% | 0.5% | ||
| Q2 24 | 1.8% | 2.0% | ||
| Q1 24 | 1.7% | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.09× | — | ||
| Q2 24 | — | 5.27× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGIO
Segment breakdown not available.
FGI
| Sanitaryware | $19.1M | 63% |
| Shower System | $5.8M | 19% |
| Kitchen And Bath Other | $3.3M | 11% |
| Bath Furniture Products | $2.3M | 7% |
